Connect Biopharma is trading 7.1% up at $2.25 in after-hours trading, following a modest regular-session dip to $2.10.
- The move appears driven by thin extended-hours liquidity and a continued rebound from earlier pre-market strength.
- No new company-specific news, earnings, or major catalysts have emerged to explain the price action.
- Broader indices are currently mixed, suggesting this is an idiosyncratic repricing rather than a market-wide reaction.